C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.
about
The Interplay of Reactive Oxygen Species, Hypoxia, Inflammation, and Sirtuins in Cancer Initiation and ProgressionPrognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapyEpstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age.The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.Increased serum C-reactive protein levels are associated with shorter survival and development of second cancers in chronic lymphocytic leukemia.A convenient prognostic score consisting of the Glasgow prognostic score and serum lactate dehydrogenase predicts clinical outcome in patients with diffuse large B-cell lymphoma.A comparison of pectoralis versus lumbar skeletal muscle indices for defining sarcopenia in diffuse large B-cell lymphoma - two are better than one.Clinical characteristics of angioimmunoblastic T-cell lymphoma in China and C-reactive protein as an independent prognostic factor.Glasgow prognostic score is superior to other inflammation-based scores in predicting survival of diffuse large B-cell lymphoma.Serum C-reactive protein and overall survival of patients with osteosarcoma.White Blood Cell and Granulocyte Counts Are Independent Predictive Factors for Prognosis of Advanced Pancreatic Caner.Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose-response meta-analysis
P2860
Q26769965-AC005D5B-0F62-4BFC-A4A3-0D7E8405FB4FQ33884484-C72E7218-98CC-43F6-9515-510CE3DE1040Q35880791-84934D7C-00F4-466E-ACB5-EB390B4B2222Q40235024-F9835EF8-52CB-4249-A917-BDEBB6F269AEQ40495494-513EDDAF-7C03-40BC-BAEF-6B762C747E2AQ40787717-3D929A62-148C-4AF0-93CC-8A1449C0F0DEQ41470871-55378071-0086-40CB-B406-A37C954A7B99Q42283444-4F1BC644-934D-473B-B903-AD2F902034B5Q47143987-0EA7AF67-0980-4C6D-9ACC-FA234789FD96Q53502320-3B426715-D4A0-4EF9-ACDB-EAC8729F29FEQ55381575-20E06034-3D21-48B2-8346-4CFC93C5AADCQ58724543-92586B48-3829-47F1-A55F-161626383ED6
P2860
C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
C-reactive protein level is a ...... arge B-cell lymphoma patients.
@ast
C-reactive protein level is a ...... arge B-cell lymphoma patients.
@en
type
label
C-reactive protein level is a ...... arge B-cell lymphoma patients.
@ast
C-reactive protein level is a ...... arge B-cell lymphoma patients.
@en
prefLabel
C-reactive protein level is a ...... arge B-cell lymphoma patients.
@ast
C-reactive protein level is a ...... arge B-cell lymphoma patients.
@en
P2093
P2860
P356
P1476
C-reactive protein level is a ...... large B-cell lymphoma patients
@en
P2093
C Beham-Schmid
D Neureiter
K T Troppan
P Neumeister
P2860
P2888
P356
10.1038/BJC.2014.277
P407
P577
2014-05-29T00:00:00Z
P5875
P6179
1030934139